Manchester Capital Management LLC maintained its stake in Cigna Corporation (NYSE:CI) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 608 shares of the health services provider’s stock at the end of the 2nd quarter. Manchester Capital Management LLC’s holdings in Cigna Corporation were worth $102,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Acadian Asset Management LLC increased its position in shares of Cigna Corporation by 43.7% during the 1st quarter. Acadian Asset Management LLC now owns 5,948 shares of the health services provider’s stock worth $871,000 after purchasing an additional 1,809 shares during the last quarter. Glen Harbor Capital Management LLC acquired a new stake in shares of Cigna Corporation during the 1st quarter worth about $403,000. Spot Trading L.L.C. increased its position in shares of Cigna Corporation by 108.9% during the 1st quarter. Spot Trading L.L.C. now owns 1,998 shares of the health services provider’s stock worth $293,000 after purchasing an additional 24,425 shares during the last quarter. State Treasurer State of Michigan increased its position in shares of Cigna Corporation by 0.6% during the 1st quarter. State Treasurer State of Michigan now owns 84,428 shares of the health services provider’s stock worth $12,368,000 after purchasing an additional 500 shares during the last quarter. Finally, First Trust Advisors LP increased its position in shares of Cigna Corporation by 83.3% during the 1st quarter. First Trust Advisors LP now owns 115,754 shares of the health services provider’s stock worth $16,957,000 after purchasing an additional 52,608 shares during the last quarter. 87.94% of the stock is owned by institutional investors and hedge funds.
CI has been the subject of a number of recent analyst reports. Cowen and Company reissued an “outperform” rating and set a $185.00 price objective (up from $160.00) on shares of Cigna Corporation in a research report on Thursday, June 1st. ValuEngine upgraded Cigna Corporation from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. UBS AG restated a “buy” rating and set a $186.00 target price (up from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. Morgan Stanley assumed coverage on Cigna Corporation in a report on Tuesday, June 6th. They set an “overweight” rating and a $184.00 target price for the company. Finally, Jefferies Group LLC restated a “buy” rating and set a $183.00 target price on shares of Cigna Corporation in a report on Thursday, June 8th. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $185.63.
Shares of Cigna Corporation (NYSE CI) opened at 182.74 on Friday. The stock has a market cap of $46.01 billion, a PE ratio of 21.08 and a beta of 0.43. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36. The company’s 50-day moving average price is $180.07 and its 200 day moving average price is $165.77.
Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The business had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. During the same quarter last year, the firm earned $1.98 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities analysts forecast that Cigna Corporation will post $10.02 EPS for the current fiscal year.
In other news, insider Jason D. Sadler sold 37,756 shares of Cigna Corporation stock in a transaction on Monday, August 7th. The stock was sold at an average price of $176.16, for a total transaction of $6,651,096.96. Following the transaction, the insider now directly owns 47,844 shares in the company, valued at approximately $8,428,199.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 247 shares of Cigna Corporation stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The disclosure for this sale can be found here. Insiders have sold a total of 70,653 shares of company stock worth $12,437,684 over the last quarter. Insiders own 1.30% of the company’s stock.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with our FREE daily email newsletter.